Cancer Hospital (Meherbhai)

Details

Name :

Cancer Hospital (Meherbhai)

Address  :

Stocking Rd,, Bistupur

Town  :

Jamshedpur

State  :

Jharkhand

Country  :

INDIA

Post Code:

831 001

Phone  :

0657 2427933

Web URL  :


Description

The Meherbai Tata Memorial Hospital was established to fulfill a longfelt need especially of the deprived tribals of the region The Hospital funded generously by Miserior and the House of Tatas functions under the guidance of Governing Council Board of Trustees and Ladies Committee of devoted social workers It has grown from an initial 24 beds to a present strength of 72 beds

The Hospital is now recognised by the Government of India as an Institute of Oncology and Cancer Research amp Training The hospital is equipped with some of the latest treatment amp diagnostic facilities and undertakes treatment of all types of malignant and other diseases The Hospital and the Diagnostic Centre have been recently computerised for more efficient working Besides serving the local population of Jharkhand it extends its services to government and non government organisations like SAIL HEC HCL CCL ACC IEL and the Railways It is a recognised referral institution and patients come from UP MP Orissa Assam West Bengal Nepal and many other states

In recognition of its outstanding performance in the field of Oncology the Hospital has been elected a member of the International Union Against Cancer and registered under the Society Act
Saudi Arabia seeks Bangalore hospitals help for telemedicine centre

By IANS Bangalore Saudi Arabia Monday sought the help of Narayana Hrudayalaya cardiac hospital in setting up a telemedicine centre in the kingdom for providing remote healthcare to its citizens The Saudi Arabian government has agreed to extend all facilities in setting up a telemedicine centre at Riyadh for providing immediate medical treatm... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More